{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T18:16:04Z","timestamp":1783188964203,"version":"3.54.6"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:00:00Z","timestamp":1778457600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012151","name":"Sanming Project of Medicine in Shenzhen","doi-asserted-by":"publisher","award":["SZZYSM202411001"],"award-info":[{"award-number":["SZZYSM202411001"]}],"id":[{"id":"10.13039\/501100012151","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82060308"],"award-info":[{"award-number":["82060308"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.tranon.2026.102814","type":"journal-article","created":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T09:26:09Z","timestamp":1779096369000},"page":"102814","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Combination of APS, HMGN1, and anti-TNFR2 antibody remodels the tumor immune microenvironment to enhance antitumor immunity in colorectal cancer"],"prefix":"10.1016","volume":"69","author":[{"given":"Liming","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haobo","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengwen","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingjie","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.tranon.2026.102814_bib0001","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"SUNG","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"9454","key":"10.1016\/j.tranon.2026.102814_bib0002","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0140-6736(05)17706-X","article-title":"Colorectal cancer","volume":"365","author":"WEITZ","year":"2005","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.tranon.2026.102814_bib0003","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41575-023-00856-2","article-title":"Preoperative chemotherapy, radiotherapy and surgical decision-making in patients with borderline resectable and locally advanced pancreatic cancer","volume":"21","author":"STOOP","year":"2024","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"9","key":"10.1016\/j.tranon.2026.102814_bib0004","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21093233","article-title":"Mechanisms of multidrug resistance in cancer chemotherapy","volume":"21","author":"BUKOWSKI","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tranon.2026.102814_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114542","article-title":"Cancer multidrug-resistance reversal by ABCB1 inhibition: a recent update","volume":"239","author":"ENGLE","year":"2022","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.tranon.2026.102814_bib0006","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13045-022-01294-4","article-title":"Exploring immunotherapy in colorectal cancer","volume":"15","author":"WENG","year":"2022","journal-title":"J. Hematol. Oncol."},{"issue":"9","key":"10.1016\/j.tranon.2026.102814_bib0007","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1038\/s43018-024-00807-z","article-title":"Integrative single-cell analysis of human colorectal cancer reveals patient stratification with distinct immune evasion mechanisms","volume":"5","author":"CHU","year":"2024","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.tranon.2026.102814_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107753","article-title":"Tumor microenvironment as a therapeutic target in cancer","volume":"221","author":"XIAO","year":"2021","journal-title":"Pharmacol. Ther."},{"issue":"8","key":"10.1016\/j.tranon.2026.102814_bib0009","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1093\/annonc\/mdw168","article-title":"Targeting the tumor microenvironment: removing obstruction to anticancer immune responses and immunotherapy","volume":"27","author":"PITT","year":"2016","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.tranon.2026.102814_bib0010","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.semcancer.2019.11.010","article-title":"Nano-immunotherapy: overcoming tumour immune evasion","volume":"69","author":"GUEVARA","year":"2021","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.tranon.2026.102814_bib0011","doi-asserted-by":"crossref","first-page":"730","DOI":"10.3389\/fimmu.2018.00730","article-title":"Exosomes and immune response in cancer: friends or foes?","volume":"9","author":"BARROS","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tranon.2026.102814_bib0012","article-title":"Immunotherapy: reshape the tumor immune microenvironment","volume":"13","author":"LV","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tranon.2026.102814_bib0013","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ijbiomac.2019.04.062","article-title":"Physicochemical, scavenging and anti-proliferative analyses of polysaccharides extracted from psyllium (Plantago ovata Forssk) husk and seeds","volume":"133","author":"PATEL M K","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.tranon.2026.102814_bib0014","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.carbpol.2019.01.064","article-title":"Polysaccharides as potential anticancer agents- a review of their progress","volume":"210","author":"KHAN","year":"2019","journal-title":"Carbohydr. Polym."},{"issue":"5","key":"10.1016\/j.tranon.2026.102814_bib0015","doi-asserted-by":"crossref","DOI":"10.3390\/ph17050636","article-title":"Anticancer mechanism of astragalus polysaccharide and its application in cancer immunotherapy","volume":"17","author":"HE","year":"2024","journal-title":"Pharmaceuticals. (Basel)"},{"key":"10.1016\/j.tranon.2026.102814_bib0016","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ijbiomac.2013.09.016","article-title":"Antitumor and immunomodulatory activity of Astragalus membranaceus polysaccharides in H22 tumor-bearing mice","volume":"62","author":"YANG","year":"2013","journal-title":"Int. J. Biol. Macromol."},{"issue":"1","key":"10.1016\/j.tranon.2026.102814_bib0017","first-page":"56","article-title":"Polysaccharide from Astragalus membranaceus promotes the activation of human peripheral blood and mouse spleen dendritic cells","volume":"19","author":"LIM","year":"2021","journal-title":"Chin. J. Nat. Med."},{"key":"10.1016\/j.tranon.2026.102814_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116172","article-title":"Astragalus polysaccharide ameliorates CD8(+) T cell dysfunction through STAT3\/Gal-3\/LAG3 pathway in inflammation-induced colorectal cancer","volume":"171","author":"LI","year":"2024","journal-title":"Biomed. PharmacOther."},{"issue":"3","key":"10.1016\/j.tranon.2026.102814_bib0019","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1007\/s12032-011-0068-9","article-title":"Astragalus polysaccharide injection integrated with vinorelbine and cisplatin for patients with advanced non-small cell lung cancer: effects on quality of life and survival","volume":"29","author":"GUO","year":"2012","journal-title":"Med. Oncol."},{"key":"10.1016\/j.tranon.2026.102814_bib0020","doi-asserted-by":"crossref","first-page":"749","DOI":"10.3389\/fonc.2019.00749","article-title":"Meta-analysis of astragalus-containing traditional chinese medicine combined with chemotherapy for colorectal cancer: efficacy and safety to tumor response","volume":"9","author":"LIN S","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.tranon.2026.102814_bib0021","article-title":"Efficacy of herbal medicines intervention for colorectal cancer patients with chemotherapy-induced gastrointestinal toxicity - a systematic review and meta-analysis","volume":"11","author":"CHEN","year":"2021","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.tranon.2026.102814_bib0022","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/imr.12577","article-title":"Alarmins and immunity","volume":"280","author":"YANG","year":"2017","journal-title":"Immunol. Rev."},{"issue":"1","key":"10.1016\/j.tranon.2026.102814_bib0023","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1084\/jem.20101354","article-title":"High-mobility group nucleosome-binding protein 1 acts as an alarmin and is critical for lipopolysaccharide-induced immune responses","volume":"209","author":"YANG","year":"2012","journal-title":"J. Exp. Med."},{"issue":"11","key":"10.1016\/j.tranon.2026.102814_bib0024","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.2217\/imt.15.76","article-title":"Harnessing the alarmin HMGN1 for anticancer therapy","volume":"7","author":"YANG","year":"2015","journal-title":"Immunotherapy."},{"issue":"21","key":"10.1016\/j.tranon.2026.102814_bib0025","doi-asserted-by":"crossref","first-page":"5989","DOI":"10.1158\/0008-5472.CAN-13-2042","article-title":"The Alarmin HMGN1 contributes to antitumor immunity and is a potent immunoadjuvant","volume":"74","author":"WEI","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.tranon.2026.102814_bib0026","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1286061","article-title":"Ansofaxine hydrochloride inhibits tumor growth and enhances Anti-TNFR2 in murine colon cancer model","volume":"14","author":"JING","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.tranon.2026.102814_bib0027","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.bbrc.2023.02.039","article-title":"Anti-TNFR2 enhanced the antitumor activity of a new HMGN1\/3M-052 stimulated dendritic cell vaccine in a mouse model of colon cancer","volume":"653","author":"ZHU","year":"2023","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.tranon.2026.102814_bib0028","first-page":"86","article-title":"A review of cancer immunotherapy toxicity","volume":"70","author":"KENNEDY","year":"2020","journal-title":"CA Cancer J. Clin."},{"issue":"3","key":"10.1016\/j.tranon.2026.102814_bib0029","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41573-018-0006-z","article-title":"Delivery technologies for cancer immunotherapy","volume":"18","author":"RILEY","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"issue":"5","key":"10.1016\/j.tranon.2026.102814_bib0030","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/cac2.12416","article-title":"Tumor microenvironment signaling and therapeutics in cancer progression","volume":"43","author":"GOENKA","year":"2023","journal-title":"Cancer Commun. (Lond)"},{"issue":"8","key":"10.1016\/j.tranon.2026.102814_bib0031","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/s41568-024-00706-6","article-title":"Cancer organoids 2.0: modelling the complexity of the tumour immune microenvironment","volume":"24","author":"POLAK","year":"2024","journal-title":"Nat. Rev. Cancer"},{"issue":"3","key":"10.1016\/j.tranon.2026.102814_bib0032","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-003982","article-title":"Combination cancer immunotherapy targeting TNFR2 and PD-1\/PD-L1 signaling reduces immunosuppressive effects in the microenvironment of pancreatic tumors","volume":"10","author":"ZHANG","year":"2022","journal-title":"J. ImmunOther. Cancer"},{"issue":"1","key":"10.1016\/j.tranon.2026.102814_bib0033","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/ijc.35130","article-title":"The implications of the TNF\u03b1-TNFR2 immune checkpoint signaling pathway in cancer treatment: From immunoregulation to angiogenesis","volume":"156","author":"EMAMALIPOUR","year":"2025","journal-title":"Int. J. Cancer"},{"issue":"12","key":"10.1016\/j.tranon.2026.102814_bib0034","doi-asserted-by":"crossref","DOI":"10.3390\/cells11121952","article-title":"The roles of TNFR2 signaling in cancer cells and the tumor microenvironment and the potency of TNFR2 targeted therapy","volume":"11","author":"TAKAHASHI","year":"2022","journal-title":"Cells,"},{"key":"10.1016\/j.tranon.2026.102814_bib0035","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.3389\/fimmu.2018.02982","article-title":"HMGN1 and R848 synergistically activate dendritic cells using multiple signaling pathways","volume":"9","author":"ALAM M M","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tranon.2026.102814_bib0036","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113541","article-title":"Application of dendritic cells in tumor immunotherapy and progress in the mechanism of anti-tumor effect of Astragalus polysaccharide (APS) modulating dendritic cells: a review","volume":"155","author":"WANG","year":"2022","journal-title":"Biomed. PharmacOther"},{"issue":"11","key":"10.1016\/j.tranon.2026.102814_bib0037","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-008898","article-title":"TNFR2 blockade promotes antitumoral immune response in PDAC by targeting activated Treg and reducing T cell exhaustion","volume":"12","author":"DEBESSET","year":"2024","journal-title":"J. ImmunOther Cancer"},{"issue":"3","key":"10.1016\/j.tranon.2026.102814_bib0038","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.celrep.2017.06.062","article-title":"Crosstalk between regulatory T cells and tumor-associated dendritic cells negates anti-tumor immunity in pancreatic cancer","volume":"20","author":"JANG","year":"2017","journal-title":"Cell Rep."},{"issue":"2","key":"10.1016\/j.tranon.2026.102814_bib0039","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.immuni.2010.08.004","article-title":"Interleukin-2 receptor signaling: at the interface between tolerance and immunity","volume":"33","author":"MALEK","year":"2010","journal-title":"Immunity."},{"issue":"12","key":"10.1016\/j.tranon.2026.102814_bib0040","first-page":"3833","article-title":"TNF-alpha is critical for antitumor but not antiviral T cell immunity in mice","volume":"117","author":"CALZASCIA","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tranon.2026.102814_bib0041","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1146\/annurev-immunol-031210-101312","article-title":"Regulation and functions of the IL-10 family of cytokines in inflammation and disease","volume":"29","author":"OUYANG","year":"2011","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.tranon.2026.102814_bib0042","doi-asserted-by":"crossref","unstructured":"BATLLE E, MASSAGU\u00e9 J. Transforming growth factor-\u03b2 signaling in immunity and cancer. Immunity, 2019, 50(4): 924-40. https:\/\/doi.org\/10.1016\/j.immuni.2019.03.024.","DOI":"10.1016\/j.immuni.2019.03.024"},{"issue":"1","key":"10.1016\/j.tranon.2026.102814_bib0043","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.smim.2014.01.008","article-title":"The two faces of IL-6 in the tumor microenvironment","volume":"26","author":"FISHER","year":"2014","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.tranon.2026.102814_bib0044","article-title":"CAF-mediated regulation of prostate cancer stem cell stemness via the Wnt\/\u03b2-catenin and SDF-1\/CXCR4 pathways in castration-resistant prostate cancer","volume":"13","author":"CHEN","year":"2025","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.tranon.2026.102814_bib0045","article-title":"Neoadjuvant Immunotherapy for MSI-H\/dMMR locally advanced colorectal cancer: new strategies and unveiled opportunities","volume":"13","author":"ZHANG","year":"2022","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.tranon.2026.102814_bib0046","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/s41575-019-0126-x","article-title":"Immunotherapy in colorectal cancer: rationale, challenges and potential","volume":"16","author":"GANESH","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"7948","key":"10.1016\/j.tranon.2026.102814_bib0047","doi-asserted-by":"crossref","first-page":"E41","DOI":"10.1038\/s41586-022-05600-5","article-title":"Author correction: the repertoire of mutational signatures in human cancer","volume":"614","author":"ALEXANDROV","year":"2023","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.tranon.2026.102814_bib0048","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S1470-2045(17)30904-X","article-title":"Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy","volume":"19","author":"DENKERT","year":"2018","journal-title":"Lancet Oncol."},{"issue":"5","key":"10.1016\/j.tranon.2026.102814_bib0049","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","article-title":"Understanding the tumor immune microenvironment (TIME) for effective therapy","volume":"24","author":"BINNEWIES","year":"2018","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.tranon.2026.102814_bib0050","article-title":"CBS promotes tumor immune evasion by reducing MHC-I stability","volume":"13","author":"YANG","year":"2026","journal-title":"Genes. Dis."},{"key":"10.1016\/j.tranon.2026.102814_bib0051","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2025.1570696","article-title":"Spatial multi-omics analysis of tumor-stroma boundary cell features for predicting breast cancer progression and therapy response","volume":"13","author":"WU","year":"2025","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.tranon.2026.102814_bib0052","article-title":"Anhydroicaritin inhibits EMT in breast cancer by enhancing GPX1 expression: a research based on sequencing technologies and bioinformatics analysis","volume":"9","author":"LI","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"20","key":"10.1016\/j.tranon.2026.102814_bib0053","doi-asserted-by":"crossref","first-page":"19740","DOI":"10.1021\/acsnano.3c03195","article-title":"Reactive oxygen species-sensitive biodegradable mesoporous silica nanoparticles harboring TheraVac elicit tumor-specific immunity for colon tumor treatment","volume":"17","author":"HUANG","year":"2023","journal-title":"ACS. Nano"},{"key":"10.1016\/j.tranon.2026.102814_bib0054","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1699902","article-title":"Astragalus polysaccharides combined with radiochemotherapy for cervical cancer: a systematic review and meta-analysis of randomized controlled studies","volume":"16","author":"SUN","year":"2025","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.tranon.2026.102814_bib0055","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.jhep.2022.03.039","article-title":"Uncoupling immune trajectories of response and adverse events from anti-PD-1 immunotherapy in hepatocellular carcinoma","volume":"77","author":"CHUAH","year":"2022","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.tranon.2026.102814_bib0056","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202405752","article-title":"Combination nanodrug delivery systems facilitate the syncretism of chemotherapy with immunotherapy to promote cancer treatment","volume":"21","author":"GUO","year":"2025","journal-title":"Small."},{"issue":"5","key":"10.1016\/j.tranon.2026.102814_bib0057","first-page":"763","article-title":"Integrated network pharmacology and experimental verification to explore the potential mechanism of San Ying decoction for treating triple-negative breast cancer","volume":"56","author":"YANG","year":"2024","journal-title":"Acta Biochim. Biophys. Sin. (Shanghai)"}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523326001518?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523326001518?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T17:26:36Z","timestamp":1783185996000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523326001518"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":57,"alternative-id":["S1936523326001518"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2026.102814","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combination of APS, HMGN1, and anti-TNFR2 antibody remodels the tumor immune microenvironment to enhance antitumor immunity in colorectal cancer","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2026.102814","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102814"}}